HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: Invest in health impact assessment

Susann Roth, senior social development specialist, Asian Development Bank, argues why a health impact assessment is essential for hard infrastructure projects.

Although I am a medical doctor, I changed my career from a clinician in surgery to public health because I wanted to have impact on people’s lives by preventing diseases, instead of treating sickness, as I would often see patients when it was too late.

The “where” and “how” we live determines our health. We all agree with this. We all want a healthy future for ourselves and for our children. Looking at the bigger picture, we know that sustainable economic development needs healthy populations – especially in this part of the world.

But health is often not valued until it’s too late, when sickness comes. The same occurs in development projects.

Developing Asia is at a crossroads. The region’s rapid economic growth comes with concerns over environmental degradation. Around 27% of diseases affecting Asians are related to the environment, according to the World Health Organization. Throughout Asia’s cities, hundreds of millions of children are exposed to air quality that is dangerous for their health.

Infrastructure projects can affect human health in many ways, creating both risks and opportunities.

For many Asian developing countries, economic development is still based on heavy industry and investments in hard infrastructure that often don’t consider the long-term impacts on human health.

Water contamination with industrial or agricultural waste such as heavy metals, pesticides, and antibiotics can cause hormonal diseases and even cancer. Threats may happen prior or during project implementation, and even long after project termination.

However, unlike environment and resettlement, health is not a traditional safeguard in development projects. It does not get the attention it deserves to ensure that whatever is built contributes to healthier and better lives for everybody.

The best way to think of health during each stage of development is through a health impact assessment (HIA).

Along with sound public health management plans and effective monitoring and mitigation systems, HIA is of utmost importance for preventing and reducing the potential negative health impacts of such projects.

HIA is an established evidence-based method for showing what are otherwise the hidden costs and benefits of infrastructure projects to human health and to the heath sector in general. It is a structured process that combines scientific evidence and community engagement to inform decision-makers about how they can maximize the health benefits and minimize the adverse health impacts of infrastructure development projects.

HIA does not look only at environmental health impacts, but rather assesses community health as a whole. It aims to ensure that benefits of development can be shared more equitably across all affected communities.

It’s important to note that HIA targets in particular the vulnerable groups that carry the brunt of the negative health impacts of development. This reflects the “leave no-one behind” philosophy of the Sustainable Development Goals.

HIA, though, doesn’t come without challenges. For instance, one of the main reasons a health component is often omitted from infrastructure cost-benefit analysis is because of the inherent difficulties in measuring health outcomes. The Disability Adjusted Life Year or DALY, a metric of the disease burden affecting community health, remains poorly accepted outside of the health sector. 

Quantification is usually limited to health outcomes that can be expressed in terms of exposure and disease (dose/response), such as for air or water pollution. Moreover, changes in population health cannot usually be attributed to any single project alone: the longer the trajectory between cause and outcome, the more confounding factors will obscure the cause-effect relationship.

While HIA cannot always draw a straight line between an infrastructure project and a specific health outcome for a defined community, it can ensure that health is on the agenda when the impact of a project is being determined. HIA can also create explicit opportunities to enhance positive health impacts and to avoid, reduce, or mitigate adverse health impacts.

For this to happen, we need to implement three paradigm shifts. First we need to develop more ambitious regional and national level policies and guidelines for HIA. We need to do more than the bare minimum required for HIA in environmental impact assessments. For example, ADB is currently assisting Greater Mekong Subregion (GMS) countries to strengthen HIA policies and guidelines.

Second we must invest in capacity development of communities, civil society, and academia to generate the evidence to support the hypothesis that the cost of not conducting HIA is more expensive in the long term. To help GMS countries achieve this goal, ADB has trained more than 600 experts from public health, environment agencies, academia and private sector on HIA and created an HIA network across the subregion.

And third, we must mobilise more resources for HIA demonstration projects and to implement public health management plans that ensure infrastructure projects have the best possible health outcomes. ADB is working on several demonstration projects that showcase HIA in various sectors throughout the GMS.

Posted on: 15/01/2018 UTC+08:00


News

Paragon Care, a leading distributor and manufacturer supplying medical equipment to hospitals, is to raise A$69.8 million (US$54.6 million) in a fully underwritten offer on the ASX.
Parkway Life REIT, which is owned by IHH Healthcare, is to acquire Konosu Nursing Home Kyoseien, a nursing rehabilitation facility in Greater Tokyo, under a sale-and-leaseback agreement with Iryouhoujin Shadan Kouaikai for ¥1.5 billion (US$13.7 million).
New Zealand-based cancer diagnostics company Pacific Edge (PEB) has entered into an agreement with MediNcrease Health Plans, a US national provider network, to make its bladder cancer diagnostic test available.
Beijing-based paediatric centre Dr Cuiyutao Healthcare has raised Series C plus funding led by New Oriental Education & Technology Group. The size of the funding has not been disclosed, but is understood to be in the millions of US dollars.
Kelantan-based Ain Medicare, which manufactures both blood and renal medical devices as well as pharmaceutical products, has raised M$20 million (US$5.1 million) in a strategic investment from Malaysian government investment company A-BIO.
Anthea Muir has been named chief executive of Australian cosmetic clinic chain Laser Clinics Australia with Paul McClintock as chairman. Muir comes from Luxottica Group while McClintock is best known as the former chairman of Medibank Private.
Harmonicare Medical, the largest private obstetrics and gynaecology specialty hospital group in China, has increased its loan to help the Rmb160 million (US$25.3 million) construction of Wuxi Harmonicare, a new obstetrics and gynaecology hospital in Wuxi, Jiangsu Province.
Higher sales have given a boost to third quarter results at medical rubber glove manufacturer Hartalega Holdings.



Analysis

A new paper from KPMG looks at the disconnect between consumer expectations and the current healthcare experience of patients in Australia.
Gan Kim Yong, Singapore’s minister for health, explains why integrated care is important in the context of an ageing population.
Not having featured before 2015, Chinese investment in Australia’s healthcare sector has surged over the past three years. It has reached A$5.5 billion (US$4.5 billion) across 16 completed deals, according to a new report from KPMG and The University of Sydney Business School.
Michael Griffiths, regional director of healthcare at specialist insurance brokers Howden, explains how insurance is an answer to the region’s healthcare crisis.
Nomaan Mirza, principal equity specialist at the International Finance Corporation, looks at healthcare equity opportunities in emerging markets.
The healthcare industry in Asia-Pacific is expected to grow at 11.1% in 2018, representing one of the fastest growing regions in the world, as the global healthcare economy averages a 4.8% annual growth rate.
Technologist, business leader, and philanthropist Bill Gates explains why global health needs the private sector.
Mitch Beaumont, Prashanth Prasad, Ulrica Sehlstedt and Mandeep Dhillon from international management consultants Arthur D. Little explain how medical technology companies can manage going digital.
my images

Podcasts

Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices